AI assistant
Sending…
Síldarvinnslan — Major Shareholding Notification 2021
May 27, 2021
2205_rns_2021-05-27_a0692b19-a6c3-44f7-a4e9-8304b84568f7.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Sildarvinnslan hf.
20 stærstu hluthafar eftir almennt útboð
| Nr | Kennitala | Nafn | Nafnverð | Hlutfall |
|---|---|---|---|---|
| 1 | 6102973079 | Samherji hf. | 554.851.710 | 32,6% |
| 2 | 4611150710 | Kjálkanes ehf. | 326.880.524 | 19,2% |
| 3 | 5502690319 | Samvinnufélag útgerðarm. Neskau | 186.476.510 | 11,0% |
| 4 | 5611952779 | Gildi - lífeyrissjóður | 168.335.052 | 9,9% |
| 5 | 6702090320 | Eignarhaldsfélagið Snæfugl ehf. | 73.000.000 | 4,3% |
| 6 | 4502902549 | Almenni lífeyrissjóðurinn | 23.858.832 | 1,4% |
| 7 | 4504042250 | Hraunlón ehf. | 17.291.530 | 1,0% |
| 8 | 6707042460 | Snæból ehf. | 16.666.666 | 1,0% |
| 9 | 4302694459 | Lífeyrissjóður verslunarmanna | 15.442.530 | 0,9% |
| 10 | 5002693839 | Olíusamlag útvegsmanna Nesk svf | 14.293.030 | 0,8% |
| 11 | 4702068450 | Stefnir - ÍS 15 | 14.250.000 | 0,8% |
| 12 | 4304079610 | Stefnir - ÍS 5 | 10.750.000 | 0,6% |
| 13 | 4411150670 | A80 ehf. | 8.333.333 | 0,5% |
| 14 | 4411159970 | Askja fagfjárfestasjóður | 8.333.330 | 0,5% |
| 15 | 5205061010 | Júpiter rekstrarfélag hf. | 8.269.170 | 0,5% |
| 16 | 6010922559 | Stapi lífeyrissjóður | 7.966.320 | 0,5% |
| 17 | 6912080520 | Landsbréf hf. | 7.549.998 | 0,4% |
| 18 | 6708989549 | Landsbréf - Úrvalsbréf | 6.616.666 | 0,4% |
| 19 | 5612049180 | Stefnir - Samval | 5.500.000 | 0,3% |
| 20 | 4412979209 | Lífeyrissjóður bankam Aldursdei | 5.000.000 | 0,3% |
| 87,0% | ||||
| Útgefið hlutafé alls | 1.700.000.000 | 100,0% |
More from Síldarvinnslan
Interim / Quarterly Report
2026
May 21
Report Publication Announcement
2026
May 20
Director's Dealing
2026
Apr 14
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 17
Earnings Release
2026
Mar 5
Report Publication Announcement
2026
Mar 4
AGM Information
2026
Feb 25
Management Reports
2026
Feb 5
Regulatory Filings
2026
Jan 16